The following stories appear in full on today's Vidyya Medical News Service Web site.
Wood dust produced in furniture and cabinet manufacture, and common talc are among the substances being considered for listing in the next federal Report on Carcinogens. To assist the National Toxicology Program in preparing the report, a group of scientific advisers will review the proposed substances Dec. 13-15 at the Wyndham City Center, 1143 New Hampshire Ave. NW, Washington, D.C. The meeting is open to the public.
For more information: Wood Dust, Talc, Estrogens, And Nickel Alloys Among Substances Being Reviewed For Inclusion In Report On Carcinogens
Bayer Diagnostics announced today that the US Food and Drug Administration (FDA) has issued a clearance of its 510(k) application for the Bayer HER-2/neu serum test for use in the follow-up and monitoring of patients with metastatic breast cancer. The Bayer serum HER-2/neu test is the first FDA-cleared blood test for measuring circulating levels of the HER-2/neu oncoprotein.
For more information: New Breast Cancer Monitoring Test Receives FDA Clearance
In the largest prospective study of cigarette smoking and colorectal cancer mortality, American Cancer Society staff researchers report finding strong evidence for classifying cancers of the colon and rectum as, in part, smoking-related.
For more information: Colorectal Cancer Traced To Smoking
An advisory panel to the US Food and Drug Administration (FDA) today took a first step to facilitate use by US cardiologists of emerging therapeutic options to help many Americans suffering from atrial fibrillation, the world's most common heart rhythm disorder. The panel, made up of physicians, other scientists and consumer members, voted to recommend that the FDA approve expansion of indications for the use of the Medtronic Jewel® AF implantable cardioverter defibrillator, which was approved by the agency for US commercial release in June 2000.
For more information: US FDA Panel Recommends New Therapy Option For Select Group Of Atrial Fibrillation Patients
Yesterday, the AMA approved recommendations regarding greater access to emergency contraception pills (ECPs). Two brand names for emergency contraceptive pills are Preven and Plan B. You can get prescribing information for Preven by searching Vidyya with keyword - Preven.
For more information: AMA Statement On Access To Emergency Contraception
Today's Vidyya articles are:
As always, we hope you enjoy the issue.